JPMorgan Upgrades RXO, Inc. (RXO) to Neutral

October 6, 2026 2:34 AM EDT Send to a Friend
JPMorgan analyst Brian Ossenbeck upgraded RXO, Inc. (NYSE: RXO) from Underweight to Neutral with a price target of $30.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login